Fabino Life

Sonipat, India Founded: 2011 • Age: 15 yrs Listed

Manufacturer of allopathic and herbal medicine products

Page last updated 12 Aug 2026

About Fabino Life

Fabino Life is a publicly listed company based in Sonipat (India) founded in 2011. Manufacturer of allopathic and herbal medicine products. Its chief executive, as recorded, is Arvind Chamoli. Its Indian entity Fabino Enterprises Limited reported revenue of ₹22.40 Cr. Fabino Life offers products and services including Allopathic Products and Juicy Jo Beverages. Its focus areas include Alternative Medicine Products.

Company details

Fabino Life was founded in 2011 and is based in Sonipat, India. Operations focus on the manufacturing of allopathic and herbal medicine products within the pharmaceuticals sector. Items produced include massage oils, utrag syrup, multi-vitamin capsules, and various food and wellness supplements. The company serves the healthcare and wellness markets through these offerings.

Headquarters Sonipat, India
Stage Public
Sectors
Healthcare
Email
••••••••
Phone
•••• ••••
Website fabinolife.com
Social LinkedIn X Facebook Instagram
Legal Name Fabino Enterprises Limited

Operational Areas

Healthcare → Alternative Medicine Products

Key Metrics

Market Cap
₹4.27 Cr
FABINO · BSE
Share Price
₹20.31
0.00% today
Revenue
₹20.84 Cr
FY 2025-26 · +15.5% YoY
EBITDA
−₹2.06 Cr
Margin -9.9%
Net Profit
−₹0.56 Cr
FY 2025-26 · -900.0% YoY
P/E (TTM)
69.9x
P/B 1.0x

Associated legal entities of Fabino Life

Fabino Life operates through Fabino Enterprises Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Fabino Enterprises Limited Listed CIN L24100HR2011PLC114093	Active	27 Oct 2011	Sonipat, Haryana	₹22.4 Cr	10	11	View details

Products & Services of Fabino Life

Fabino Life offers a comprehensive portfolio of products and services, including Allopathic Products and Juicy Jo Beverages.

Allopathic Products

Pharmaceuticals

Allopathic tablets and injectables are sourced and offered for health purposes, including active pharmaceutical ingredients.

Juicy Jo Beverages

Beverages

Fruit-flavored drinks, such as those with lychee and mango flavors, are manufactured and distributed to meet refreshment needs.

Board of directors of Fabino Enterprises Limited (Fabino Life)

Fabino Enterprises Limited is the primary company behind Fabino Life. The board of Fabino Enterprises Limited currently have 9 directors; the longest-serving is Arihant Jain, appointed in 2021. 13 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Arihant Jain DIN 08280553	Director	14 Jan 2021	5 yrs 9 mo	Fabino Enterprises Limited
Tesu Alakh DIN 07300250	Director	27 Oct 2021	5 yrs	Fabino Enterprises Limited
Aditya Mahavir Jain DIN 09353344	Managing Director	06 Dec 2021	4 yrs 10 mo	Fabino Enterprises Limited
Sumit Malik DIN 09615815	Director	22 Sep 2022	4 yrs 1 mo	Fabino Enterprises Limited
Vandana Jain DIN 00004347	Director	28 Aug 2025	1 yr 2 mo	Fabino Enterprises Limited
Deepali Singla DIN 11442242	Additional Director	26 Dec 2025	10 mo	Fabino Enterprises Limited
Rahul Mangla DIN 06978016	Additional Director	29 Sep 2026	1 mo	Fabino Enterprises Limited
Sarthak Goyal DIN 07754955	Additional Director	29 Sep 2026	1 mo	Fabino Enterprises Limited
Samrat Vardhan Dutta DIN 11918207	Additional Director	29 Sep 2026	1 mo	Fabino Enterprises Limited

People of Fabino Life

1 people are tracked at Fabino Life (1 in leadership).

Name	Role	Group
Arvind Chamoli	CEO	Leadership

Premium access

Complete people profiles for Fabino Life

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

Full employee list
Team structure
Board tenure
Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Fabino Life

Fabino Life is a publicly listed company on the BSE with ticker symbol FABINO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

IPO date13 Jan 2022
Listed onBSE: 543444
Listed entityFabino Enterprises Limited
Exchange sectorHealth technology
ISININE0DRT01018
Share price₹20.31 (+4.96% on the day) · 2026-05-11
Volume (last session)18,000
Analyst consensusNo rating

Financials of Fabino Life

Exchange-reported figures of Fabino Enterprises Limited, the listed company behind Fabino Life (BSE: FABINO).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹20.84 Cr

+15.5% YoY

EBITDA

−₹2.06 Cr

-1816.7% YoY

Profit After Tax

−₹0.56 Cr

-900.0% YoY

Net Worth

₹3.65 Cr

-13.1% YoY

Total Assets

₹5.27 Cr

-12.2% YoY

Total Debt

₹1.62 Cr

-9.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Income statement
Revenue	20.84	18.04	21.08	3.36
Revenue growth	+15.5%	-14.4%	+527.4%	-
EBITDA	(2.06)	0.12	0.12	0.04
EBITDA margin	-9.9%	+0.7%	+0.6%	+1.2%
Profit before tax	(0.74)	0.20	0.05	0.02
Net profit	(0.56)	0.07	0.04	0.02
Net profit margin	-2.7%	+0.4%	+0.2%	+0.6%
EPS (₹)	(2.66)	0.29	0.17	0.05
Balance sheet
Total assets	5.27	6.00	5.46	4.57
Net worth	3.65	4.20	4.14	4.11
Total debt	1.62	1.79	1.27	0.41
Cash & bank	0.20	0.24	0.06	0.24
Net working capital	4.66	5.37	5.02	4.34
Cash flow
Cash from operations	0.19	0.12	(0.77)	(0.68)
Cash from investing	0.07	(0.29)	(0.28)	(0.01)
Cash from financing	(0.30)	0.35	0.86	0.34

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	11.43	18.04	6.08	3.36	4.20	3.06	7.52
Revenue growth	-36.6%	+196.7%	+81.0%	-20.0%	+37.3%	-59.3%	-
EBITDA	(1.54)	0.17	0.11	0.04	0.10	0.05	0.32
EBITDA margin	-13.5%	+0.9%	+1.8%	+1.2%	+2.4%	+1.6%	+4.3%
Profit before tax	(0.47)	0.26	0.06	0.02	0.07	0.02	0.10
Net profit	(0.35)	0.13	0.05	0.02	0.05	0.01	0.07
Net profit margin	-3.1%	+0.7%	+0.8%	+0.6%	+1.2%	+0.3%	+0.9%
EPS (₹)	(1.71)	0.63	0.23	0.05	0.22	0.25	4.59
Balance sheet
Total assets	5.04	5.90	5.04	4.57	4.22	1.70	1.90
Net worth	3.93	4.29	4.16	4.11	4.10	1.30	0.67
Total debt	1.11	1.61	0.84	0.41	0.05	0.31	1.08
Cash & bank	0.16	0.22	0.02	0.24	0.59	0.07	0.17
Net working capital	4.46	5.32	4.66	4.34	3.95	1.47	1.24
Cash flow
Cash from operations	0.59	(0.12)	(2.99)	(0.68)	(1.90)	(0.45)	2.44
Cash from investing	(0.01)	(0.29)	(0.18)	(0.01)	(0.05)	(0.10)	0.00
Cash from financing	(0.63)	0.61	0.43	0.34	2.47	0.45	(2.37)

Particulars	Sep 2021	Jun 2021
Revenue	0.92	1.13
Other income	0.01	0.00
Total expenses	1.00	1.10
EBITDA	(0.08)	0.03
EBITDA margin	-8.7%	+2.7%
Depreciation	(0.01)	0.01
Interest	0.00	0.00
Profit before tax	(0.06)	0.02
Tax	(0.01)	0.01

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 29 Oct 2026

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Revenue	20.84	18.04	21.08	3.36
Revenue growth	+15.5%	-14.4%	+527.4%	-
Other income	1.56	0.29	0.01	0.02
Total expenses	22.90	17.92	20.96	3.32
Employee cost	0.00	0.28	0.18	0.19
EBITDA	(2.06)	0.12	0.12	0.04
EBITDA margin	-9.9%	+0.7%	+0.6%	+1.2%
Depreciation	0.11	0.08	0.04	0.03
Interest	0.13	0.13	0.04	0.01
Profit before tax	(0.74)	0.20	0.05	0.02
Tax	(0.18)	0.13	0.01	0.00
Net profit	(0.56)	0.07	0.04	0.02
Net profit margin	-2.7%	+0.4%	+0.2%	+0.6%
EPS (₹)	(2.66)	0.29	0.17	0.05

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Equity & liabilities
Share capital	2.10	2.10	2.10	2.10
Reserves & surplus	1.55	2.10	2.04	2.01
Shareholders' funds (net worth)	3.65	4.20	4.14	4.11
Minority interest	0.00	0.00	0.00	0.00
Secured loans	0.11	0.14	0.00	0.00
Unsecured loans	1.51	1.65	1.27	0.41
Total debt	1.62	1.79	1.27	0.41
Total liabilities	5.27	6.00	5.46	4.57
Assets
Gross block	0.78	0.89	0.59	0.15
Net block	0.37	0.55	0.34	0.15
Capital work in progress	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00
Inventories	1.06	1.20	1.33	1.19
Sundry debtors	16.46	14.17	12.61	2.53
Cash & bank balances	0.20	0.24	0.06	0.24
Loans & advances	3.81	1.42	0.92	0.82
Total current assets	21.53	17.03	14.92	4.78
Total current liabilities	16.87	11.66	9.90	0.44
Net working capital	4.66	5.37	5.02	4.34
Total assets	5.27	6.00	5.46	4.57

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Opening cash	0.24	0.06	0.24	0.59
Net cash from operating activities	0.19	0.12	(0.77)	(0.68)
Net cash from investing activities	0.07	(0.29)	(0.28)	(0.01)
Net cash from financing activities	(0.30)	0.35	0.86	0.34
Net change in cash	(0.05)	0.18	(0.18)	(0.35)
Closing cash	0.20	0.24	0.06	0.24

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Growth
Sales growth	+15.5%	-14.4%	+527.4%	-
EBITDA growth	-1816.7%	0.0%	+200.0%	-
PBT growth	-	+300.0%	+150.0%	+9997.0%
Net income growth	-900.0%	+75.0%	+100.0%	-
Revenue CAGR (3Y)	+83.7%	-	-	-
Profitability & leverage
Net income margin	-2.7%	+0.4%	+0.2%	+0.6%
Return on capital employed	-	+5.6%	+1.8%	+0.4%
Return on net worth	-	+1.4%	+1.0%	+0.2%
Debt / equity	-	0.37	0.20	0.10
Long-term debt / equity	-	0.37	0.20	0.10
Interest cover	-5.99	325.00	50.00	100.00
Efficiency & per share
Fixed asset turnover	-	24.54	56.97	22.40
Inventory turnover	-	14.26	16.73	2.82
Debtors turnover	-	1.35	2.78	1.33
EPS (₹)	(2.66)	0.29	0.17	0.05
Dividend per share (₹)	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	20.02	19.73	19.59

Particulars	Sep 2021	Jun 2021
Revenue	0.92	1.13
Other income	0.01	0.00
Total expenses	1.00	1.10
EBITDA	(0.08)	0.03
EBITDA margin	-8.7%	+2.7%
Depreciation	(0.01)	0.01
Interest	0.00	0.00
Profit before tax	(0.06)	0.02
Tax	(0.01)	0.01

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	11.43	18.04	6.08	3.36	4.20	3.06	7.52
Revenue growth	-36.6%	+196.7%	+81.0%	-20.0%	+37.3%	-59.3%	-
Other income	1.30	0.29	0.00	0.02	0.01	0.00	0.00
Total expenses	12.97	17.87	5.97	3.32	4.10	3.01	7.20
Employee cost	0.00	0.27	0.16	0.19	0.19	0.09	0.21
EBITDA	(1.54)	0.17	0.11	0.04	0.10	0.05	0.32
EBITDA margin	-13.5%	+0.9%	+1.8%	+1.2%	+2.4%	+1.6%	+4.3%
Depreciation	0.10	0.07	0.03	0.03	0.03	0.02	0.02
Interest	0.13	0.13	0.02	0.01	0.01	0.01	0.20
Profit before tax	(0.47)	0.26	0.06	0.02	0.07	0.02	0.10
Tax	(0.12)	0.13	0.01	0.00	0.02	0.01	0.03
Net profit	(0.35)	0.13	0.05	0.02	0.05	0.01	0.07
Net profit margin	-3.1%	+0.7%	+0.8%	+0.6%	+1.2%	+0.3%	+0.9%
EPS (₹)	(1.71)	0.63	0.23	0.05	0.22	0.25	4.59

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	2.10	2.10	2.10	2.10	2.10	1.20	0.15
Reserves & surplus	1.83	2.19	2.06	2.01	2.00	0.10	0.52
Shareholders' funds (net worth)	3.93	4.29	4.16	4.11	4.10	1.30	0.67
Secured loans	0.11	0.14	0.00	0.00	0.00	0.00	0.00
Unsecured loans	1.00	1.47	0.84	0.41	0.05	0.31	1.08
Total debt	1.11	1.61	0.84	0.41	0.05	0.31	1.08
Total liabilities	5.04	5.90	5.04	4.57	4.22	1.70	1.90
Assets
Gross block	0.78	0.77	0.48	0.15	0.35	0.35	0.22
Net block	0.37	0.47	0.24	0.15	0.17	0.16	0.08
Capital work in progress	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.05	0.05	0.05	0.00	0.00	0.00	0.00
Inventories	0.93	1.20	1.33	1.19	1.71	0.47	0.29
Sundry debtors	12.68	8.62	6.22	2.53	1.44	1.33	2.33
Cash & bank balances	0.16	0.22	0.02	0.24	0.59	0.07	0.17
Loans & advances	2.97	2.38	1.55	0.82	0.62	0.16	0.13
Total current assets	16.74	12.42	9.12	4.78	4.36	2.03	2.92
Total current liabilities	12.28	7.10	4.46	0.44	0.41	0.56	1.68
Net working capital	4.46	5.32	4.66	4.34	3.95	1.47	1.24
Total assets	5.04	5.90	5.04	4.57	4.22	1.70	1.90

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	0.22	0.02	0.24	0.59	0.07	0.17	0.10
Net cash from operating activities	0.59	(0.12)	(2.99)	(0.68)	(1.90)	(0.45)	2.44
Net cash from investing activities	(0.01)	(0.29)	(0.18)	(0.01)	(0.05)	(0.10)	0.00
Net cash from financing activities	(0.63)	0.61	0.43	0.34	2.47	0.45	(2.37)
Net change in cash	(0.05)	0.20	(2.75)	(0.35)	0.52	(0.10)	0.07
Closing cash	0.16	0.22	0.02	0.24	0.59	0.07	0.17

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	-36.6%	+196.7%	+81.0%	-20.0%	+37.3%	-59.3%	-
EBITDA growth	-1005.9%	+54.6%	+175.0%	-60.0%	+100.0%	-84.4%	-
PBT growth	-	+333.3%	+200.0%	-71.4%	+250.0%	-80.0%	+9997.0%
Net income growth	-369.2%	+160.0%	+150.0%	-60.0%	+400.0%	-85.7%	-
Revenue CAGR (3Y)	+50.4%	+62.6%	+25.7%	-23.6%	+15.0%	-	-
EBITDA CAGR (3Y)	-	+19.4%	+30.1%	-50.0%	-32.1%	-	-
Profitability & leverage
Net income margin	-3.1%	+0.7%	+0.8%	+0.6%	+1.2%	+0.3%	+0.9%
Return on capital employed	-	+7.1%	+1.9%	+0.5%	+2.7%	+2.8%	+11.5%
Return on net worth	-	+3.1%	+1.2%	+0.2%	+1.9%	+3.1%	+11.0%
Debt / equity	-	0.29	0.15	0.05	0.06	0.70	2.83
Long-term debt / equity	-	0.29	0.15	0.05	0.06	0.70	0.96
Interest cover	-7.93	130.00	25.00	100.00	14.29	33.33	66.67
Efficiency & per share
Fixed asset turnover	-	28.86	19.30	13.44	12.00	10.74	34.18
Inventory turnover	-	14.26	4.83	2.32	3.85	8.05	2.88
Debtors turnover	-	2.41	1.39	1.69	3.03	1.67	3.08
EPS (₹)	(1.71)	0.63	0.23	0.05	0.22	0.25	4.59
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	20.42	19.80	19.59	19.54	10.86	44.84

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Fabino Life (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Revenue	Employees
Schwabe India	Homeopathic medicine manufacturing and online retail in India.	1898	Noida, Uttar Pradesh, India	USD 26.35 M	1,192
Healthmug	Operates an online store specializing in ayurvedic and homeopathic medicines.	2016	Delhi, Delhi, India	USD 1.25 M	16
Jiva Ayurveda	Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.	1992	Faridabad, Haryana, India	USD 10.08 M	570

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Fabino Life

When was Fabino Life founded?

Fabino Life was founded in 2011.

Where is Fabino Life located?

Fabino Life is headquartered in Sonipat, India. It is registered at Sonipat, Haryana, India.

Who is the CEO of Fabino Life?

Arvind Chamoli is the CEO of Fabino Life, as recorded in our data.

What is the annual revenue of Fabino Life?

The primary company behind Fabino Life, Fabino Enterprises Limited, reported revenue of ₹22.40 Cr for FY 2026, up 16% year on year.

What does Fabino Life do?

What products or services does Fabino Life offer?

Fabino Life offers Allopathic Products and Juicy Jo Beverages.

Is Fabino Life publicly traded?

Yes, Fabino Life is publicly traded on BSE under the ticker symbol FABINO.

Which legal entities are associated with Fabino Life?

Fabino Life operates through Fabino Enterprises Limited.

Who are the directors of Fabino Life?

The legal entities of Fabino Life currently have 11 directors, including Tesu Alakh, Aditya Mahavir Jain, Pankaj Jain and others.

Fabino Life

About Fabino Life

Company details

Operational Areas of Fabino Life

Associated legal entities of Fabino Life

Products & Services of Fabino Life

Board of directors of Fabino Enterprises Limited (Fabino Life)

People of Fabino Life

Complete people profiles for Fabino Life

IPO & Listings of Fabino Life

Financials of Fabino Life

Financial Highlights

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Financial Statements

Top companies in Alternative Medicine Products

Related news about Fabino Life

Complete news archive for Fabino Life

Frequently Asked Questions about Fabino Life

About Fabino Life

Company details

Operational Areas of Fabino Life

Associated legal entities of Fabino Life

Products & Services of Fabino Life

Board of directors of Fabino Enterprises Limited (Fabino Life)

People of Fabino Life

Complete people profiles for Fabino Life

IPO & Listings of Fabino Life

Financials of Fabino Life

Financial Highlights

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr Consolidated Standalone AnnualQuarterly

Financial Statements

Top companies in Alternative Medicine Products

Related news about Fabino Life

Complete news archive for Fabino Life

Frequently Asked Questions about Fabino Life

Financial summary ₹ Cr